Economics of coronary stenting and GPIIb/IIIa blockade | Zendy

W Weintraub | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Economics of coronary stenting and GPIIb/IIIa blockade

Author(s) -

W Weintraub

Publication year - 2001

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1053/euhj.2001.2704

Subject(s) - medicine , coronary stenting , blockade , cardiology , ticagrelor , percutaneous coronary intervention , myocardial infarction , stent , receptor , restenosis

lipidaemic agents (usually a statin). If coronary arterial spasm seems a likely aetiological agent in such a patient, I also prescribe a vasodilator, i.e. a calcium channel blocker, an ACE inhibitor, or an angiotensin receptor blocker. These patients represent a very interesting subset of individuals with myocardial infarction. I am convinced that they will continue to be the subject of clinical investigation in the future in an effort to understand the pathophysiological process that results in their transient episode of coronary arterial obstruction. J. S. ALPERT Department of Medicine, University of Arizona Health Science Center, Tucson, Arizona, U.S.A. References

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research